tiprankstipranks
CohBar Almost Quadruples amid Morphogenesis Merger
PremiumMarket NewsCohBar Almost Quadruples amid Morphogenesis Merger
12M ago
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy
PremiumPress Releases
CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy
12M ago
CohBar treatment of idiopathic pulmonary fibrosis granted orphan status
PremiumThe Fly
CohBar treatment of idiopathic pulmonary fibrosis granted orphan status
1y ago
CohBar Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress
PremiumPress ReleasesCohBar Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress
2y ago
CohBar to Announce 2022 Second Quarter Financial Results and Provide Business Update on August 15, 2022
PremiumPress Releases
CohBar to Announce 2022 Second Quarter Financial Results and Provide Business Update on August 15, 2022
2y ago
These 3 Penny Stocks Could Rally Over 100%, Says Roth Capital
PremiumStock Analysis & Ideas
These 3 Penny Stocks Could Rally Over 100%, Says Roth Capital
3y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100